ReviewTranslational lung cancer research2020
Optimizing current standard of care therapy for stage III non-small cell lung cancer.
Vivek Verma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it